FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

17571211000001109: NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Aug 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60672801000001113 NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60672901000001119 NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) Is a Product containing precisely carbimazole 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) Has active ingredient Carbimazole false Inferred relationship Existential restriction modifier
NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient Carbimazole true Inferred relationship Existential restriction modifier
NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) Is a NeoMercazole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) 100 tablet Has AMP True NeoMercazole 5 tablets (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start